Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
about
Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarctionFluid biopsy for solid tumors: a patient's companion for lifelong characterization of their diseaseClinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor CellsCirculating Tumor Cells: A Window Into Tumor Development and Therapeutic EffectivenessThe promise of circulating tumor cell analysis in cancer managementAdvances in rare cell isolation: an optimization and evaluation studyCirculating tumor cells: the substrate of personalized medicine?Isolation and retrieval of circulating tumor cells using centrifugal forces.Emerging proteomics biomarkers and prostate cancer burden in Africa.Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cellsCirculating tumor microemboli diagnostics for patients with non-small-cell lung cancer.Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.In vitro validation of an ultra-sensitive scanning fluorescence microscope for analysis of circulating tumor cells.Mechanical aspects of microtubule bundling in taxane-treated circulating tumor cellsMicrosieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.An automated high-throughput counting method for screening circulating tumor cells in peripheral bloodAn observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation.Multivalent conjugation of antibody to dendrimers for the enhanced capture and regulation on colon cancer cellsA novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolationA physical sciences network characterization of circulating tumor cell aggregate transportPrognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohortOptical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient.Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patientsQuantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient.Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniquesTechnical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patientsCirculating tumor cells in non-small cell lung carcinomaCirculating tumor cells as emerging tumor biomarkers in lung cancerIsolation and characterization of circulating tumor cells in prostate cancer.Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma.Detecting circulating tumor cells: current challenges and new trends.Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.The prothrombotic activity of cancer cells in the circulationInertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
P2860
Q24564065-FC32331E-A050-4A79-BEF2-C24F822189B4Q24623374-F3FC0FC0-C82E-4F91-8FB4-D065E5C4B0BAQ26744828-26C5FDE0-92D7-4F12-A728-97FF2324C2AEQ26827815-E61C0E0D-8BA3-4BB7-A43B-977C442B2905Q27022113-F37AB6A8-0960-4A62-85E9-6884E7884113Q28817931-ADB1CCB9-5DBD-429A-B2E7-D6DF61F1FC27Q30465827-27B79AF8-15CB-4AC8-A96A-1F28798892FEQ30535350-4DF15E68-2E34-4130-9F8A-E7AF5FA94D5BQ33914221-AD20EE43-0028-4237-8C0E-512299FB48F8Q33988851-733B2CA5-02A5-4B05-99AD-11944DF47930Q34093217-C692C1E1-67E9-4E26-8977-1AB599897EADQ34108738-5DD41C74-01FD-4A7E-9261-EF42AA3F3F3CQ34130345-C5C0AA0E-DF13-4165-8110-F6BE5EAA06DCQ34144105-CC2A7F27-BD47-411E-AFC8-EC6C9C7BA986Q34396921-2D8A3CC4-EB43-4CA4-BDFB-413BC3F9D82EQ34578347-C93BEF57-001A-4B45-8560-96040642BF7AQ34826007-BD09594A-7BEE-49D8-A845-1B168258CD4EQ35034831-F11681E8-B12C-4CE6-8082-299517E23035Q35227397-B6312210-6DF5-4CC3-BF3F-1A910E8B5264Q35538013-78418286-62D4-4306-899B-6E1BA0AD1C66Q35622438-39BD1A84-BD28-42C9-BDF0-34D4062F3E95Q36070763-29AA67B2-5F88-4640-A27E-E5A22AF8F575Q36101423-BEA23ED8-299A-4016-BBB1-C2FBE01D2476Q36141581-BE6CF43B-99D7-4C70-897C-0C2BD5B64117Q36150788-3E300667-69D1-49BA-A88A-DEE088A0F06EQ36193912-738727DB-216E-4095-A65C-93BE3A249535Q36211316-CCFAD77D-861E-44DC-8472-9C4C5C6C8A9BQ36242936-2766D57B-FA41-477C-A372-1A38D4B1AB36Q36287422-86F24C9A-C398-4823-A19C-2B59BE6FAB5BQ36287629-0E49E5F0-4190-4858-AA45-C275AFE0F9ECQ36287633-A9334F68-7350-422A-AC19-C904E1C41946Q36310363-98B43D95-E87A-44B5-8B34-7E72DA684198Q36356608-7563C100-DD82-4139-8BD0-CB4BE44FBCF1Q36437111-FBC93FF2-9B41-42F1-A867-6EA1655868AFQ36915318-E1747C7F-373E-45BC-B173-30523E908578Q37075334-6CC69B15-7CC6-400A-A3B8-8424CA81FC42Q37088087-D771F552-64BD-4839-A722-D38B05133417Q37140168-7D273CB5-26E3-4ED0-8A0E-2E8EED578350Q37255590-C078D8C2-D35D-4E05-8BCC-CCE5F5CFEA90Q37269406-46D24800-1197-4CB7-90EC-AD135D3D8BD6
P2860
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@ast
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@en
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@nl
type
label
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@ast
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@en
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@nl
prefLabel
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@ast
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@en
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
@en
P2093
Anand Kolatkar
Andrew H Ko
Craig Yoshioka
Daniel Lazar
David Nelson
Dena Marrinucci
Ethan Schram
Franziska Baehring
Jorge Nieva
P2860
P304
P3181
P356
10.1088/1478-3975/9/1/016003
P407
P577
2012-02-01T00:00:00Z